Healthcare -
Biotechnology - NASDAQ - US
$ 0.5755
2.97 %
$ 168 M
Market Cap
-0.73
P/E
LYEL - CASH FROM OPERATIONS
Cash from Operations LYEL - Lyell Immunopharma, Inc.
-164 M
LAST VALUE
-13.87%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR